Corporate Archives - ARC Oxford

Oxford BioDynamics shortlisted for a strategic Government initiative to improve cancer immunotherapy.

ARC OXFORD UNVEILS NEXT GENERATION ASCENT DEVELOPMENT

Accession Therapeutics raises £25m

ARC secures over 50 percent of all leasing transactions across Oxfordshire in 2023

Fortnum and Mason and Ivy Farm collaborate on the future of farming

SELOXIUM JOINS GROWING SCIENCE COMMUNITY AT ARC OXFORD

FluoRok awarded £750k grant by UKRI’s Faraday Battery Challenge

Fluorok becomes latest member to join ARC Oxford as university spin-out scales

Ultromics granted FDA Breakthrough Device Designation

Biotech company Oxford BioDynamics awarded $963,000

OMass Therapeutics makes move to ARC Oxford as it announces new phase of growth

ARC Oxford becomes latest member of Advanced Oxford

you've seen 24 of 29 News

1
2
3